Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms
<b>Background/Objectives</b>: The mammalian target of the rapamycin (mTOR) signaling pathway is a central regulator of cell growth, proliferation, metabolism, and survival. Dysregulation of mTOR signaling contributes to many human diseases, including cancer, diabetes, and obesity. Theref...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/12/1677 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846103249366548480 |
|---|---|
| author | Sulaiman K. Marafie Eman Alshawaf Fahd Al-Mulla Jehad Abubaker Anwar Mohammad |
| author_facet | Sulaiman K. Marafie Eman Alshawaf Fahd Al-Mulla Jehad Abubaker Anwar Mohammad |
| author_sort | Sulaiman K. Marafie |
| collection | DOAJ |
| description | <b>Background/Objectives</b>: The mammalian target of the rapamycin (mTOR) signaling pathway is a central regulator of cell growth, proliferation, metabolism, and survival. Dysregulation of mTOR signaling contributes to many human diseases, including cancer, diabetes, and obesity. Therefore, inhibitors against mTOR’s catalytic kinase domain (KD) have been developed and have shown significant antitumor activities, making it a promising therapeutic target. The ATP–KD interaction is particularly important for mTOR to exert its cellular functions, and such inhibitors have demonstrated efficient attenuation of overall mTOR activity. <b>Methods</b>: In this study, we screened the Traditional Chinese Medicine (TCM) database, which enlists natural products that capture the relationships between drugs targets and diseases. Our aim was to identify potential ATP-competitive agonists that target the mTOR-KD and compete with ATP to bind the mTOR-KD serving as potential potent mTOR inhibitors. <b>Results</b>: We identified two compounds that demonstrated interatomic interactions similar to those of ATP–mTOR. The conformational stability and dynamic features of the mTOR-KD bound to the selected compounds were tested by subjecting each complex to 200 ns molecular dynamic (MD) simulations and molecular mechanics/generalized Born surface area (MM/GBSA) to extract free binding energies. We show the effectiveness of both compounds in forming stable complexes with the mTOR-KD, which is more effective than the mTOR-KD–ATP complex with more robust binding affinities. <b>Conclusions</b>: This study implies that both compounds could serve as potential therapeutic inhibitors of mTOR, regulating its function and, therefore, mitigating human disease progression. |
| format | Article |
| id | doaj-art-db4c1622514a403c909600ca213e5c95 |
| institution | Kabale University |
| issn | 1424-8247 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceuticals |
| spelling | doaj-art-db4c1622514a403c909600ca213e5c952024-12-27T14:46:03ZengMDPI AGPharmaceuticals1424-82472024-12-011712167710.3390/ph17121677Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding MechanismsSulaiman K. Marafie0Eman Alshawaf1Fahd Al-Mulla2Jehad Abubaker3Anwar Mohammad4Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Dasman 15462, KuwaitBiochemistry and Molecular Biology Department, Dasman Diabetes Institute, Dasman 15462, KuwaitTranslational Research Department, Dasman Diabetes Institute, Dasman 15462, KuwaitBiochemistry and Molecular Biology Department, Dasman Diabetes Institute, Dasman 15462, KuwaitBiochemistry and Molecular Biology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait<b>Background/Objectives</b>: The mammalian target of the rapamycin (mTOR) signaling pathway is a central regulator of cell growth, proliferation, metabolism, and survival. Dysregulation of mTOR signaling contributes to many human diseases, including cancer, diabetes, and obesity. Therefore, inhibitors against mTOR’s catalytic kinase domain (KD) have been developed and have shown significant antitumor activities, making it a promising therapeutic target. The ATP–KD interaction is particularly important for mTOR to exert its cellular functions, and such inhibitors have demonstrated efficient attenuation of overall mTOR activity. <b>Methods</b>: In this study, we screened the Traditional Chinese Medicine (TCM) database, which enlists natural products that capture the relationships between drugs targets and diseases. Our aim was to identify potential ATP-competitive agonists that target the mTOR-KD and compete with ATP to bind the mTOR-KD serving as potential potent mTOR inhibitors. <b>Results</b>: We identified two compounds that demonstrated interatomic interactions similar to those of ATP–mTOR. The conformational stability and dynamic features of the mTOR-KD bound to the selected compounds were tested by subjecting each complex to 200 ns molecular dynamic (MD) simulations and molecular mechanics/generalized Born surface area (MM/GBSA) to extract free binding energies. We show the effectiveness of both compounds in forming stable complexes with the mTOR-KD, which is more effective than the mTOR-KD–ATP complex with more robust binding affinities. <b>Conclusions</b>: This study implies that both compounds could serve as potential therapeutic inhibitors of mTOR, regulating its function and, therefore, mitigating human disease progression.https://www.mdpi.com/1424-8247/17/12/1677mTORkinase domainATPmTOR inhibitorsnatural compoundsmolecular simulation |
| spellingShingle | Sulaiman K. Marafie Eman Alshawaf Fahd Al-Mulla Jehad Abubaker Anwar Mohammad Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms Pharmaceuticals mTOR kinase domain ATP mTOR inhibitors natural compounds molecular simulation |
| title | Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms |
| title_full | Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms |
| title_fullStr | Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms |
| title_full_unstemmed | Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms |
| title_short | Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms |
| title_sort | targeting mtor kinase with natural compounds potent atp competitive inhibition through enhanced binding mechanisms |
| topic | mTOR kinase domain ATP mTOR inhibitors natural compounds molecular simulation |
| url | https://www.mdpi.com/1424-8247/17/12/1677 |
| work_keys_str_mv | AT sulaimankmarafie targetingmtorkinasewithnaturalcompoundspotentatpcompetitiveinhibitionthroughenhancedbindingmechanisms AT emanalshawaf targetingmtorkinasewithnaturalcompoundspotentatpcompetitiveinhibitionthroughenhancedbindingmechanisms AT fahdalmulla targetingmtorkinasewithnaturalcompoundspotentatpcompetitiveinhibitionthroughenhancedbindingmechanisms AT jehadabubaker targetingmtorkinasewithnaturalcompoundspotentatpcompetitiveinhibitionthroughenhancedbindingmechanisms AT anwarmohammad targetingmtorkinasewithnaturalcompoundspotentatpcompetitiveinhibitionthroughenhancedbindingmechanisms |